Work

Clinical outcomes of first-line venetoclax-based regimens vs second-generation BTK inhibitors in CLL/SLL: A retrospective cohort study

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-4540

Authors: Angimar Uriepero, Jose Milano, Chidiebube Ugwu, Sam King, Gabor Varadi

Institutions: Thomas Jefferson University, Jefferson Einstein Philadelphia Hospital, Universidad Central de Venezuela

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417018363

Cites:

Cited by:

Related to: